Boston Scientific (BSX) Tops Q2 EPS by 2c
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $47.80 +1.81%
Revenue Growth %: +3.7%
Financial Fact:
Selling, general and administrative expenses: 772M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.7%
Financial Fact:
Selling, general and administrative expenses: 772M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.44, $0.02 better than the analyst estimate of $0.42. Revenue for the quarter came in at $3.24 billion versus the consensus estimate of $3.21 billion.
GUIDANCE:
Boston Scientific sees FY2022 EPS of $1.74-$1.77, versus the consensus of $1.76.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
- Torrid Holdings Inc. (CURV) Tops Q2 EPS by 8c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
